{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Morgantown",
      "address_1": "781 Chestnut Ridge Rd",
      "reason_for_recall": "CGMP Deviations: Trace amounts of an impurity, N-nitrosodimethylamine (NDMA) was detected in the API Nizatidine.",
      "address_2": "",
      "product_quantity": "16,944 bottles of 30 capsules",
      "code_info": "Lot # 3082876, exp. date  January 2020  Lot # 3082877, exp. date         January 2020",
      "center_classification_date": "20200120",
      "distribution_pattern": "Product was distributed to wholesalers, distributors , retail pharmacies, charitable organizations and mail order pharmacies throughout the United States and the product may have been further distributed.",
      "state": "WV",
      "product_description": "Nizatidine Capsules, USP 300 mg, Rx Only, Mylan Pharmaceuticals Inc., NDC 0378-5300-93.",
      "report_date": "20200129",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Mylan Pharmaceuticals Inc.",
      "recall_number": "D-0792-2020",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "84607",
      "termination_date": "20210519",
      "more_code_info": "",
      "recall_initiation_date": "20200107",
      "postal_code": "26505-2730",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}